Autologuos transplantation of bronchial basal cells( Regend Therapeutics)

N/A

Report date: 2024/01/02 20:03:52

Base Information

Drug NameAutologuos transplantation of bronchial basal cells( Regend Therapeutics)
Drug Alias NameN/A
ClassificationCell and gene therapy > Cell therapy > Somatic cell > Bronchial basal cell therapyCell and gene therapy > Cell therapy > Donor > Autologous
Mechanisms of ActionCell replacements
TargetsNot applicable
Therapy Area/IndicationsPulmonary Disease, Chronic Obstructive
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesRegend Therapeutics Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesGuangzhou Institute Of Respiratory HealthRegend Therapeutics Co Ltd
Inactive CompaniesN/A
Active IndicationsPulmonary Disease, Chronic Obstructive
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A